Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components

García Ramírez, Marta; Hernández Pascual, Cristina; Simó Canonge, Rafael; Ramos Abellán, Hugo

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	García Ramírez, Marta
dc.contributor.author	Hernández Pascual, Cristina
dc.contributor.author	Simó Canonge, Rafael
dc.contributor.author	Ramos Abellán, Hugo
dc.date.accessioned	2025-10-14T08:56:49Z
dc.date.available	2025-10-14T08:56:49Z
dc.date.issued	2025-08
dc.identifier.citation	Simó R, Ramos H, García-Ramírez M, Hernández C. Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components. Eye. 2025 Aug;39(12):2485–6.
dc.identifier.issn	1476-5454
dc.identifier.uri	http://hdl.handle.net/11351/13845
dc.description	Sitagliptina; Diabetis; Barrera hematoretiniana
dc.description.sponsorship	HR was recipient of a grant from Ministerio de Ciencia, Innovación y Universidades (BES-2017-081690) and the research was funded by Instituto de Salud Carlos III and co-funded by the European Union (ICI20/00129). The study funder was not involved in the design of the study.
dc.language.iso	eng
dc.publisher	Springer Nature
dc.relation.ispartofseries	Eye;39(12)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Retinopatia diabètica - Tractament
dc.subject	Antigen CD26 - Inhibidors - Ús terapèutic
dc.subject	Diabetis
dc.subject.mesh	Blood-Retinal Barrier
dc.subject.mesh	Dipeptidyl-Peptidase IV Inhibitors
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Diabetic Retinopathy
dc.subject.mesh	/drug therapy
dc.subject.mesh	Diabetes Mellitus
dc.title	Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41433-025-03924-w
dc.subject.decs	barrera hematorretinal
dc.subject.decs	inhibidores de la dipeptidil-peptidasa IV
dc.subject.decs	/uso terapéutico
dc.subject.decs	retinopatía diabética
dc.subject.decs	/farmacoterapia
dc.subject.decs	diabetes mellitus
dc.relation.publishversion	https://doi.org/10.1038/s41433-025-03924-w
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Simó R, Hernández C] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain. Department de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ramos H, García-Ramírez M] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain
dc.identifier.pmid	40664761
dc.identifier.wos	001529603700001
dc.rights.accessrights	info:eu-repo/semantics/openAccess